HY-P99183-1mg
|
MedChemexpress LLC
|
Abituzumab [CAS 1105038-73-0]
|
|
Cancer-Kinase/protease
|
|
HY-P99183-10mg
|
MedChemexpress LLC
|
Abituzumab [CAS 1105038-73-0]
|
|
Cancer-Kinase/protease
|
|
HY-P99183-5mg
|
MedChemexpress LLC
|
Abituzumab [CAS 1105038-73-0]
|
|
Cancer-Kinase/protease
|
|
HY-P99351-1mg
|
MedChemexpress LLC
|
Andecaliximab [CAS 1518996-49-0]
|
|
Cancer-Kinase/protease
|
|
HY-P99351-10mg
|
MedChemexpress LLC
|
Andecaliximab [CAS 1518996-49-0]
|
|
Cancer-Kinase/protease
|
|
HY-P99351-5mg
|
MedChemexpress LLC
|
Andecaliximab [CAS 1518996-49-0]
|
|
Cancer-Kinase/protease
|
|
HY-P99007-1mg
|
MedChemexpress LLC
|
Aprutumab [CAS 1634620-63-5]
|
|
Cancer-Kinase/protease
|
|
HY-P99007-5mg
|
MedChemexpress LLC
|
Aprutumab [CAS 1634620-63-5]
|
|
Cancer-Kinase/protease
|
|
HY-P99353-1mg
|
MedChemexpress LLC
|
Ascrinvacumab [CAS 1463459-96-2]
|
|
Cancer-Kinase/protease
|
|
HY-P99353-10mg
|
MedChemexpress LLC
|
Ascrinvacumab [CAS 1463459-96-2]
|
|
Cancer-Kinase/protease
|
|
HY-P99353-5mg
|
MedChemexpress LLC
|
Ascrinvacumab [CAS 1463459-96-2]
|
|
Cancer-Kinase/protease
|
|
HY-P99010-1mg
|
MedChemexpress LLC
|
Bemarituzumab [CAS 1952272-74-0]
|
|
Cancer-Kinase/protease
|
|
HY-P99010-10mg
|
MedChemexpress LLC
|
Bemarituzumab [CAS 1952272-74-0]
|
|
Cancer-Kinase/protease
|
|
HY-P99010-5mg
|
MedChemexpress LLC
|
Bemarituzumab [CAS 1952272-74-0]
|
|
Cancer-Kinase/protease
|
|
HY-P9906-1mg
|
MedChemexpress LLC
|
Bevacizumab [CAS 216974-75-3]
|
|
Cancer-Kinase/protease
|
|
HY-P9906-10mg
|
MedChemexpress LLC
|
Bevacizumab [CAS 216974-75-3]
|
|
Cancer-Kinase/protease
|
|
HY-P9906-5mg
|
MedChemexpress LLC
|
Bevacizumab [CAS 216974-75-3]
|
|
Cancer-Kinase/protease
|
|
HY-P99258-1mg
|
MedChemexpress LLC
|
Brontictuzumab [CAS 1447814-75-6]
|
|
Cancer-Kinase/protease
|
|
HY-P99258-10mg
|
MedChemexpress LLC
|
Brontictuzumab [CAS 1447814-75-6]
|
|
Cancer-Kinase/protease
|
|
HY-P99258-5mg
|
MedChemexpress LLC
|
Brontictuzumab [CAS 1447814-75-6]
|
|
Cancer-Kinase/protease
|
|
HY-P9905-1mg
|
MedChemexpress LLC
|
Cetuximab [CAS 205923-56-4]
|
|
Cancer-Kinase/protease
|
|
HY-P9905-25mg
|
MedChemexpress LLC
|
Cetuximab [CAS 205923-56-4]
|
|
Cancer-Kinase/protease
|
|
HY-P9905-5mg
|
MedChemexpress LLC
|
Cetuximab [CAS 205923-56-4]
|
|
Cancer-Kinase/protease
|
|
HY-P9905-50mg
|
MedChemexpress LLC
|
Cetuximab [CAS 205923-56-4]
|
|
Cancer-Kinase/protease
|
|
HY-P99284-1mg
|
MedChemexpress LLC
|
Dalotuzumab [CAS 1005389-60-5]
|
|
Cancer-Kinase/protease
|
|